top of page


Critical Thinking in Critical Care Medicine


BICARICU-2: Sodium Bicarbonate reduces need for renal replacement but does not change mortality.
This trial is a follow up to the BICARICU trial which used of sodium bicarbonate in critically ill patients with metabolic acidemia. Primary outcome of mortality was not different; however, renal replacement need was again lower in the intervention group with a NNT of 7.
Martin Cearras, MD
12 hours ago2 min read
Â
Â
Â


BICAR-ICU trial: in a subgroup with severe acidemia and severe Acute Kidney Injury a bicarbonate infusion reduces need for renal replacement therapy and potentially mortality at 28 days.
Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre,...

David Goldenberg, DO
Jan 24 min read
Â
Â
Â


STARRT - AKI trial. Harm and unnecessary Renal Replacement Therapy (RRT) when RRT is started early in the ICU.
Critical Appraisal of the Starrt - AKI trial for early renal replacement in the ICU

Peter Tofts, MD
Oct 22, 20243 min read
Â
Â
Â
bottom of page